Clinical Trial Update: Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole [Phase 1]

View source ↗

Summary

First-in-man Phase 1 clinical trial of fexinidazole for human African trypanosomiasis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human African Trypanosomiasis

Drugs mentioned

• Fexinidazole (fexinidazole)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Human African Trypanosomiasis | Phase 1 | Status: COMPLETED